Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)

Ministry of Social Affairs and Health

The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine, required for the vaccinations in the National Immunisation Program in Finland. The contract period is one (1) year during 2027 - 2028. The procurement contains three (3) one (1) -year contract period renewals (1 + 1 + 1) to extend the contract for the years 2029, 2030 and 2031. Estimated quantity for the contract period including contract period renewals is 560,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2025 SUPPLIES Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service Annex 6 Bank Details Annex 7 Quality Agreement

Määräaika

Tarjousten vastaanottamisen määräaika oli 2026-05-18. Hankinta julkaistiin 2026-04-15.

Kuka?

• Ministry of Social Affairs and Health

Mitä?

• Systeemisesti vaikuttavat infektiolääkkeet › Rokotteet

Missä?

• Helsinki-Uusimaa › Helsinki-Uusimaa

Hankintojen historia

Päivämäärä	Asiakirja
2026-04-15	hankintailmoitus
2026-05-07	hankintailmoitus

hankintailmoitus (2026-04-15)
Kohde
Hankinnan laajuus
Otsikko: Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)
Viitenumero: THL/1109/2.02.06/2026
Lyhyt kuvaus:

Sopimustyyppi: Tavarat
Tuotteet/palvelut: Rokotteet 📦
Kuvaus
Sisäinen tunniste: THL/1109/2.02.06/2026
Lisätietoja:

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC). Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program. According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine. Therefore, the procurement is not divided into lots. More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7) CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler. The Contract period is two (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Lisätietoja

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC).

Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program.

According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine.

Therefore, the procurement is not divided into lots.

More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib

The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.

If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)

CONTRACT PERIOD

The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.

However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler.

The Contract period is two (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses.

After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".

Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Lisätuotteet/palvelut:

Farmaseuttiset tuotteet 📦

Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit 📦

Maa: Suomi 🇫🇮
Suorituspaikka: Helsinki-Uusimaa 🏙️
Kesto: 48 kuukautta
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Tämä sopimus voidaan uusia ✅
Kuvaus
Sopimuksen optiokausien enimmäismäärä: 3
Lisätietoja uusimisesta:

After the Contract period, THL shall reserve a right for three (3) one (1) -year Contract period renewals (1+1+1). THL should extend the Contract period with one (1), two (2) or three (3) contract period renewals at a time. If THL decides to exercise the Contract period renewal, the Supplier shall commit to the following extensions of the Contract: The Contract consists of contract period renewals for the periods 2029, 2030 and 203. Estimated quantity for one contract period renewal is 140,000 doses (+/- 20%).

Myöntämisperusteet
Hinta ✅
Hinta (painotus): 100
Otsikko
Erän tunnistenumero: LOT-0000

Menettely
Toimenpiteen tyyppi
Avoin menettely ✅
Oikeusperusta: Direktiivi 2014/24/EU
Menettelyn tärkeimmät piirteet:

An open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive tendering, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.

Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2026-05-18 09:00:00 📅
Tarjousten avaamista koskevat ehdot: 2026-05-18 09:01:00 📅
Tarjousten avaamista koskevat ehdot (paikka): Please note that the opening of tenders is an early estimate date. The opening of the tenders is not a public event. The online connection to the Cloudia Supplier Portal can be periodically slow and the download time will take time. Please fill out the Tenders information in good time before the deadline expires.
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6 kuukautta
Tarjouspyynnön ehdot
Tarjoaja voi jättää useamman kuin yhden tarjouksen
Tarjousten avaamisen päivämäärä: 2026-05-18 09:01:00 📅
Paikka:

Please note that the opening of tenders is an early estimate date. The opening of the tenders is not a public event. The online connection to the Cloudia Supplier Portal can be periodically slow and the download time will take time. Please fill out the Tenders information in good time before the deadline expires.

Sähköinen laskutus: Pakollinen
Sähköistä tilaamista käytetään ✅
Sähköistä maksua käytetään ✅
Lisätietojen pyytämisen määräaika: 2026-04-27 09:00:00 📅
Myöntämisperusteet
Kiintolukutyyppi: Kiinteä arvo (yhteensä)
Tarjouspyynnön ehdot
Sopimukseen sisältyy suoritusehtoja ✅

Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot
Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot: For further details please see Call for Tenders.

Hankintaviranomainen
Nimi ja osoitteet
Nimi: Ministry of Social Affairs and Health
Kansallinen rekisterinumero: 0244685-8
Postiosoite: P.O. BOX 33
Postinumero: 00023
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Yhteyspiste: Hankintayksikkö
Sähköposti: kilpailutus@thl.fi 📧
Puhelin: +358 295246000 📞
URL: https://stm.fi/en/frontpage 🌏
Hankintaviranomaisen tyyppi
Ministeriö tai muu kansallinen tai liittovaltiotason viranomainen
Päätoimi
Terveys
Viestintä
Asiakirjojen URL-osoite: https://tarjouspalvelu.fi/thl?id=602429&tpk=2cb9f686-7c14-4611-a520-5eecdc067464 🌏
Osallistumisen URL-osoite: https://tarjouspalvelu.fi/thl?id=602429&tpk=2cb9f686-7c14-4611-a520-5eecdc067464 🌏
Tarjouksen/hakemuksen jättäminen sähköisesti: Pakollinen

Täydentävät tiedot
Lisätietoja

Lisätietoja

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC).

Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program.

According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine.

Therefore, the procurement is not divided into lots.

More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib

The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.

If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)

CONTRACT PERIOD

The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.

However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler.

The Contract period is two (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses.

After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".

Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi 📧
Puhelin: +358 295643300 📞
URL: http://www.oikeus.fi/markkinaoikeus 🌏
Uudelleentarkastelumenettely
Tarkat tiedot uudelleentarkastelumenettelyjen määräajasta (määräajoista):

The appeal must be submitted in writing within 14 days of the party receiving the notification of the procurement decision, including the appeal instructions. The date of receipt of the notification is not included in the appeal period. The appeal must be received on the last day of the appeal period before the end of the Market Court's opening hours.

Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Lähde: OJS 2026/S 074-260792 (2026-04-15)

hankintailmoitus (2026-05-07)
Kohde
Kuvaus
Lisätietoja:

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC). Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program. According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine. Therefore, the procurement is not divided into lots. More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7) CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler. The Contract period is one (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Lisätietoja

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC).

Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program.

According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine.

Therefore, the procurement is not divided into lots.

More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib

The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.

If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)

CONTRACT PERIOD

The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.

However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler.

The Contract period is one (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses.

After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".

Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Täydentävät tiedot
Lisätietoja

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC). Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program. According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine. Therefore, the procurement is not divided into lots. More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7) CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler. The Contract period is one (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Lisätietoja

The purpose of the Ministry of Social Affairs and Health (STM) and the Customer is to procure a Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine required for vaccinations in the National Immunisation Program in Finland. The tendered vaccine shall be suitable for children over two months. The Customer prefers syringes without fixed needles. The tendered vaccine shall be indicated for active immunisation against Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b disease according to the Summary of Product Characteristics (SPC).

Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity seeks to enhance efficiency in the use of public funds and to organise its procurement activities so that procurements can be carried out with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and considering environmental and social aspects. These fundamental aims will be achieved by procuring one suitable vaccine for the National Immunisation Program.

According to the Communicable Diseases Act (1227/2016), the Finnish Institute for Health and Welfare is obliged to supervise the implementation of the National Immunisation Program and other general vaccinations, and to monitor the implementation and impact of these vaccinations. For practical and effective implementation and supervision of the National Immunisation Program, it is appropriate to procure one suitable vaccine.

Therefore, the procurement is not divided into lots.

More information about National Immunisation Program and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/viitosrokote-lapsille-dtap-ipv-hib

The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".

The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.

If the Supplier has modified vaccine available/releases a modified vaccine during the contract period, the Parties may agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. (Followed by General Terms of Public Procurements in Supply Contracts, Section 4.7)

CONTRACT PERIOD

The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties.

However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler.

The Contract period is one (1) year from the date defined previously above and the estimated quantity to be purchased for this period is 140,000 +/- 20% doses.

After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals".

Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

Muutokset
Alkuperäiseen ilmoitukseen korjattava teksti
Jakson numero: PROCEDURE
Muut lisätiedot

There was a discrepancy in the document "Call for Tenders," page 3, regarding the contract period: “The contract period is two (1) year from the date…”. The correct contract period is one (1) year.

Muutoksen pääasiallinen syy: Julkaisijan virheen korjaaminen
Tiedot muutoksista
Muutettavan ilmoituksen edellinen versio: 69ddea29-f53f-4b41-9f80-eeed92c77a07-01
Lähde: OJS 2026/S 089-319010 (2026-05-07)

Uudet hankinnat asiaan liittyvissä luokissa 🆕

Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet (>20 uudet hankinnat)

Farmaseuttiset tuotteet (9)

Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit

Systeemisesti vaikuttavat infektiolääkkeet

Rokotteet